Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07214 | 32579753 | J Food Sci | Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice. | 2020 | Details |
| A07215 | 32579743 | Mol Nutr Food Res | Fat-Shaped Microbiota Affects Lipid Metabolism, Liver Steatosis, and Intestinal Homeostasis in Mice Fed a Low-Protein Diet. | 2020 | Details |
| A07216 | 32579269 | J Gastroenterol Hepatol | High risk of colorectal polyps in men with non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07218 | 32578019 | Hepatol Int | Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division. | 2020 | Details |
| A07219 | 32577775 | Inflamm Res | Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease. | 2020 | Details |
| A07220 | 32577122 | Nutr Metab (Lond) | TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of PPARα promoter. | 2020 | Details |
| A07222 | 32576204 | Lipids Health Dis | The value of the atherogenic index of plasma in non-obese people with non-alcoholic fatty liver disease: a secondary analysis based on a cross-sectional study. | 2020 | Details |
| A07223 | 32576050 | Gut Microbes | Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice. | 2020 | Details |
| A07224 | 32576036 | Endocr Pract | ROLE OF ANDROGEN IN LIVER FAT CONTENT IN WOMEN: METABOLICALLY ADVANTAGEOUS OR DISADVANTAGEOUS? | 2020 | Details |
| A07225 | 32575640 | Molecules | Effect of Carotenoids from Phaeodactylum tricornutum on Palmitate-Treated HepG2 Cells. | 2020 | Details |
| A07226 | 32574665 | Life Sci | Combination of luteolin and lycopene effectively protect against the "two-hit" in NAFLD through Sirt1/AMPK signal pathway. | 2020 | Details |
| A07227 | 32574624 | Gastroenterology | IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis. | 2020 | Details |
| A07228 | 32574416 | Mol Nutr Food Res | Mitochondrial Dysfunction is a Key Pathway that Links Saturated Fat Intake to the Development and Progression of NAFLD. | 2020 | Details |
| A07229 | 32573635 | Food Funct | Studying the effects of sea cucumber ovum powder on nonalcoholic fatty liver disease by proteomics techniques in a rat model. | 2020 | Details |
| A07230 | 32573567 | Food Funct | Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways. | 2020 | Details |
| A07231 | 32573497 | JCI Insight | Leptin decreases de novo lipogenesis in patients with lipodystrophy. | 2020 | Details |
| A07232 | 32573385 | Radiology | The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07233 | 32573017 | J Gastroenterol Hepatol | Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis. | 2020 | Details |
| A07234 | 32572955 | J Cell Physiol | Expression of NF-κB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial. | 2020 | Details |
| A07235 | 32572817 | Hepatol Int | Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease. | 2020 | Details |
| A07236 | 32572196 | Nat Biomed Eng | Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin. | 2020 | Details |
| A07237 | 32572126 | Sci Rep | Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. | 2020 | Details |
| A07238 | 32571616 | Nutr Metab Cardiovasc Dis | Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies. | 2020 | Details |
| A07239 | 32571278 | BMC Endocr Disord | Relationships between menstrual status and obesity phenotypes in women: a cross-sectional study in northern China. | 2020 | Details |
| A07240 | 32571100 | J Endourol | Nonalcoholic Fatty Liver Disease Is an Independent Risk Factor for Nephrolithiasis in Women: Findings from NHANES III. | 2020 | Details |
| A07241 | 32571083 | Ann Pharmacother | A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07242 | 32570937 | Nutrients | Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation. | 2020 | Details |
| A07243 | 32570776 | Int J Mol Sci | Epidemiology: Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan. | 2020 | Details |
| A07244 | 32569680 | Metabolism | Metabolic liver disease in diabetes - From mechanisms to clinical trials. | 2020 | Details |
| A07245 | 32569304 | PLoS One | Effect of TSH on Non-Alcoholic Fatty Liver Disease (NAFLD) independent of obesity in children of predominantly Hispanic/Latino ancestry by causal mediation analysis. | 2020 | Details |
| A07246 | 32569201 | Medicine (Baltimore) | Effectiveness and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: Protocol for systematic review and meta-analysis. | 2020 | Details |
| A07247 | 32568734 | J Pediatr Endocrinol Metab | Definition and early diagnosis of metabolic syndrome in children. | 2020 | Details |
| A07248 | 32567701 | Hepatology | An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD. | 2020 | Details |
| A07249 | 32566632 | Ann Transl Med | A hook-effect-free homogeneous light-initiated chemiluminescence assay: is it reliable for screening and the quantification of the hepatitis B surface antigen? | 2020 | Details |
| A07250 | 32566571 | Ann Transl Med | Association between ratio of γ-glutamyl transpeptidase to high-density lipoprotein cholesterol and prevalence of nonalcoholic fatty liver disease and metabolic syndrome: a cross-sectional study. | 2020 | Details |
| A07251 | 32566547 | Can J Gastroenterol Hepatol | Effect of Melatonin as an Antioxidant Drug to Reverse Hepatic Steatosis: Experimental Model. | 2020 | Details |
| A07252 | 32566546 | Can J Gastroenterol Hepatol | Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07253 | 32566176 | Food Sci Nutr | Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice. | 2020 | Details |
| A07254 | 32566088 | Oxid Med Cell Longev | Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis. | 2020 | Details |
| A07255 | 32565595 | Indian J Pharmacol | Comparison of the efficacy of oral fenugreek seeds hydroalcoholic extract versus placebo in nonalcoholic fatty liver disease; a randomized, triple-blind controlled pilot clinical trial. | 2020 | Details |
| A07257 | 32564624 | Ann Saudi Med | Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation. | 2020 | Details |
| A07258 | 32564543 | Zhonghua Liu Xing Bing Xue Za Zhi | [Relationship between waist circumference trajectory and new-onset non alcoholic fatty liver disease in the non-obese population]. | 2020 | Details |
| A07259 | 32563249 | Lipids Health Dis | Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. | 2020 | Details |
| A07260 | 32562818 | Pharmacol Res | ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis. | 2020 | Details |
| A07261 | 32562600 | Immunity | Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis. | 2020 | Details |
| A07264 | 32561910 | Am J Clin Pathol | Steatohepatitis-Like Changes in Hepatocellular Adenoma. | 2020 | Details |
| A07265 | 32561908 | J Clin Endocrinol Metab | Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth. | 2020 | Details |
| A07266 | 32561790 | Sci Rep | The Role of Bone Morphogenetic Protein Signaling in Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07267 | 32559839 | Biomed Pharmacother | Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine. | 2020 | Details |
| A07268 | 32559768 | Horm Metab Res | Effects and Safety of Sitagliptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A07269 | 32559586 | J Nutr Biochem | Citrus reticulata Blanco peel extract ameliorates hepatic steatosis, oxidative stress and inflammation in HF and MCD diet-induced NASH C57BL/6 J mice. | 2020 | Details |
| A07270 | 32559194 | PLoS Med | Predicting and elucidating the etiology of fatty liver disease: A machine learning modeling and validation study in the IMI DIRECT cohorts. | 2020 | Details |
| A07271 | 32559142 | Acta Clin Belg | Non-alcoholic fatty liver disease: correlation with hyperuricemia in a European Mediterranean population. | 2020 | Details |
| A07273 | 32559006 | Liver Int | Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patients. | 2020 | Details |
| A07274 | 32558346 | Liver Int | Oxidative stress is associated with suspected non-alcoholic fatty liver disease and all-cause mortality in the general population. | 2020 | Details |
| A07275 | 32558201 | Liver Int | Early life famine exposure, adulthood obesity patterns and the risk of nonalcoholic fatty liver disease. | 2020 | Details |
| A07276 | 32558189 | Liver Int | The risk of pregnancy-associated hypertension in women with nonalcoholic fatty liver disease. | 2020 | Details |
| A07278 | 32557804 | Hepatology | Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation. | 2021 | Details |
| A07279 | 32557741 | J Gastroenterol Hepatol | Clinical profile of non-alcoholic fatty liver disease in nonobese patients. | 2020 | Details |
| A07280 | 32557192 | Hepatol Int | Portal inflammation predicts renal dysfunction in patients with nonalcoholic fatty liver disease. | 2020 | Details |
| A07281 | 32556752 | Surg Endosc | Long-term effects of one-anastomosis gastric bypass on liver histopathology in NAFLD cases: a prospective study. | 2020 | Details |
| A07282 | 32556446 | Eur J Nutr | S-allylmercaptocysteine improves nonalcoholic steatohepatitis by enhancing AHR/NRF2-mediated drug metabolising enzymes and reducing NF-κB/IκBα and NLRP3/6-mediated inflammation. | 2020 | Details |
| A07283 | 32555989 | Arch Endocrinol Metab | Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center. | 2020 | Details |
| A07284 | 32555268 | Sci Rep | Improved survival after treatments of patients with nonalcoholic fatty liver disease associated hepatocellular carcinoma. | 2020 | Details |
| A07285 | 32555123 | Med Sci Monit | Association between Cardiorespiratory Fitness, Relative Grip Strength with Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A07286 | 32554851 | Aging (Albany NY) | CTRP13 attenuates the expression of LN and CAV-1 Induced by high glucose via CaMKKβ/AMPK pathway in rLSECs. | 2020 | Details |
| A07287 | 32554245 | Biomed Pharmacother | 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice. | 2020 | Details |
| A07288 | 32554158 | J Electrocardiol | The prevalence and correlates of T-wave inversion in lead III in non-obese men. | 2020 | Details |
| A07289 | 32553943 | Alcohol | Effects of low ethanol consumption on nonalcoholic steatohepatitis in mice. | 2020 | Details |
| A07290 | 32553933 | Food Chem Toxicol | Development of a QSAR model to predict hepatic steatosis using freely available machine learning tools. | 2020 | Details |
| A07291 | 32553927 | Life Sci | Liver macrophages mediate effects of downhill running and caloric restriction on nonalcoholic fatty liver disease of high fat diet-fed mice. | 2020 | Details |
| A07292 | 32553765 | Gastroenterology | Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis. | 2020 | Details |
| A07293 | 32553762 | Gastroenterology | Human Pluripotent Stem Cell-Derived Organoids as Models of Liver Disease. | 2020 | Details |
| A07294 | 32553647 | Ann Hepatol | Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease. | 2020 | Details |
| A07295 | 32553151 | Lancet Gastroenterol Hepatol | Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. | 2020 | Details |
| A07296 | 32552211 | Expert Rev Gastroenterol Hepatol | Genetics and epigenetics purpose in nonalcoholic fatty liver disease. | 2020 | Details |
| A07297 | 32552182 | Expert Opin Investig Drugs | Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH). | 2020 | Details |
| A07298 | 32550887 | Exp Ther Med | Inhibition of acetyl-CoA carboxylase by PP-7a exerts beneficial effects on metabolic dysregulation in a mouse model of diet-induced obesity. | 2020 | Details |
| A07299 | 32550751 | World J Gastroenterol | Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management. | 2020 | Details |
| A07300 | 32550210 | J Diabetes Metab Disord | Mediterranean diet for patients with non-alcoholic fatty liver disease, a systematic review and meta-analysis of observational and clinical investigations. | 2020 | Details |
| A07301 | 32550166 | J Diabetes Metab Disord | The landscape of microbiota research in Iran; a bibliometric and network analysis. | 2020 | Details |
| A07302 | 32548202 | ACG Case Rep J | Hepatic Steatosis Resulting From LMNA-Associated Familial Lipodystrophy. | 2020 | Details |
| A07303 | 32548088 | Front Chem | Rapamycin-Loaded mPEG-PLGA Nanoparticles Ameliorate Hepatic Steatosis and Liver Injury in Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A07304 | 32546802 | Sci Rep | Liver-specific knockout of B cell lymphoma 6 suppresses progression of non-alcoholic steatohepatitis in mice. | 2020 | Details |
| A07305 | 32546794 | Nat Commun | Hepatic HuR modulates lipid homeostasis in response to high-fat diet. | 2020 | Details |
| A07306 | 32546444 | Dig Liver Dis | Increased risk of acute liver failure by pain killer drugs in NAFLD: Focus on nuclear receptors and their coactivators. | 2020 | Details |
| A07307 | 32545650 | Nutrients | Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study. | 2020 | Details |
| A07308 | 32545637 | Biology (Basel) | Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps. | 2020 | Details |
| A07309 | 32545403 | Int J Mol Sci | Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. | 2020 | Details |
| A07310 | 32545215 | Diagnostics (Basel) | Could SCGF-Beta Levels Be Associated with Inflammation Markers and Insulin Resistance in Male Patients Suffering from Obesity-Related NAFLD? | 2020 | Details |
| A07311 | 32544504 | Eur J Pharmacol | Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation. | 2020 | Details |
| A07312 | 32544255 | Hepatology | From NAFLD to MAFLD: Implications of a Premature Change in Terminology. | 2021 | Details |
| A07313 | 32543284 | Expert Opin Pharmacother | Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis. | 2020 | Details |
| A07314 | 32542253 | Food Funct | S-petasin inhibits lipid accumulation in oleic acid-induced HepG2 cells through activation of the AMPK signaling pathway. | 2020 | Details |
| A07315 | 32541499 | Medicine (Baltimore) | Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis. | 2020 | Details |
| A07316 | 32541457 | Medicine (Baltimore) | Association between non-alcoholic fatty liver and acute cerebral infarction: a protocol of systematic review and meta-analysis. | 2020 | Details |
| A07317 | 32541239 | Eur J Gastroenterol Hepatol | The impact of primary biliary cholangitis on non-alcoholic fatty liver disease. | 2021 | Details |
| A07318 | 32540813 | Ann Biol Clin (Paris) | [Mutltifaceted biological roles of adiponectin]. | 2020 | Details |
| A07319 | 32540736 | Diabetes Metab Syndr | Metabolic dysfunction associated fatty liver disease increases risk of severe Covid-19. | 2020 | Details |
| A07320 | 32540565 | Environ Pollut | Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice. | 2020 | Details |